11.2025
Built for discovery
Operon™ is GATC Health’s proprietary, AI-powered discovery engine, where predictive intelligence meets collaborative innovation.
Multiomic data integration enables Operon to simulate the full complexity of human biology, predicting a drug candidate’s efficacy, safety, and success rates up to 11x better than industry averages – before clinical testing even begins.
Explore Platform Capabilities:
96%
savings
in pre-clinical cost
Less than $5 million, compared to industry average of $140 million
2-5
years faster
pre-clinical phase
Years faster to the clinic. Years longer market exclusivity.
80%
success
rate or greater
11x improvement over industry average
Drug discovery timelines that span months, not years
Together with GATC Health’s decades of drug discovery and development expertise, the Operon engine provides an objective, pragmatic view of drug candidates, helping teams collaborate more closely than ever to devise strategy and pressure-test results for faster delivery of innovative therapies.
4-6 months
18-24 months
36-48 months
GATC Health Operon Platform
4-6 months
AI Assisted
18-24 months
Traditional
36-48 months
GATC Health Operon Platform
Development in 4-6 months
Discovery in 4-6 Months
GATC Health’s Operon platform simulates biology end-to-end and delivers 3–5 optimized compounds ready for preclinical testing in record time, while other methods are still in discovery
AI Assisted
Development in 18-24 months
Discovery in 18-24 Months
While AI-assisted drug discovery speeds up screening via virtual modeling, it still demands 18–24 months of intensive trial-and-error, wet-lab synthesis, hit-to-lead cycles, and rigorous validation of compounds for safety/efficacy before preclinical testing
Traditional
Development in 36-48 months
Discovery in 36-48 Months
Traditional drug discovery relies on extensive high-throughput screening and demands 36–48 months of exhaustive trial-and-error, repeated wet-lab synthesis, lengthy hit-to-lead cycles, and thorough compound validation for safety/efficacy before preclinical testing
Real speed. Real results. Real impact.
Operon is more than just a platform. It’s a comprehensive process and partnership model that dramatically accelerates drug discovery and development – from uncovering novel drug IP and repurposing shelved candidates to extending indications and optimizing clinical development.
The definitive AI report for predictive risk intelligence
Powered by Operon, the Derisq™ AI Report by GATC Health delivers objective, AI-powered insights that help biotech leaders and investors prioritize assets and predict outcomes – all before committing capital or entering the clinic.
Building your next breakthrough, together
Partner with people who put your science and success first. Uniting the industry’s experts in AI, biology, drug development, and business, GATC Health is ready to help you get to work on what’s next.
